Industry News

Thai scientists discover antibody to cure Ebola
Sanofi Pasteur Introduces 4-Strain Influenza Vaccine in Canada
Merck Completes Sale of Consumer Care Business to Bayer AG for $14.2 Billion
Thai scientists discover antibody to cure Ebola
Sanofi Pasteur Introduces 4-Strain Influenza Vaccine in Canada
2014 Career & Salary Survey: IN CHECK
Thinking outside the box about inside the box
MesotheliomaHelp.org Reacts to FDA's Approval of Keytruda Cancer Drug
Baxter to Form New Global Innovation and R&D Center near Boston for Its Biopharmaceuticals Business
Baxter to Form New Global Innovation and R&D Center near Boston for Its Biopharmaceuticals Business
Intuitive Surgical Receives FDA Clearance for First Single-Site(R) Wristed Needle Driver for da Vinci(R) Si(R) Surgical System
FDA Approves NeuroGenetic Pharmaceuticals Application to Begin Clinical Trials for Its NGP 555 Compound to Treat and Prevent Alzheimer�s Disease
First Patients Enrolled in Landmark Clinical Study to Evaluate the Role of Packaging in Improving Medication Adherence
Horizon Discovery To Buy Sage Labs For Up To USD48 Million
First Patients Enrolled in Landmark Clinical Study to Evaluate the Role of Packaging in Improving Medication Adherence
Allergan Announces FDA Approves Revised Indication for OZURDEX� (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema
Allergan Announces FDA Approves Revised Indication for OZURDEX� (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema
Intuitive Surgical Receives FDA Clearance for First Single-Site(R) Wristed Needle Driver for da Vinci(R) Si(R) Surgical System
Amag Pharma to spend $675M on Lumara Health
Amag Pharma to spend $675M on Lumara Health
Horizon Discovery To Buy Sage Labs For Up To USD48 Million
Amag Pharma to spend $675M on Lumara Health
Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health -- Expands Perrigo's Specialty Rx portfolio to include extended topical products in the women's healthcare category--
Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals
Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health -- Expands Perrigo's Specialty Rx portfolio to include extended topical products in the women's healthcare category--